Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
about
Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published DataReview of Osteosarcoma and Current ManagementEfficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysisAssessing the percent of necrosis after neoadjuvant chemotherapy with 24hr infusional cisplatin/3 days Doxorubicin intermittent with Ifosfamide-Doxorubicin for osteosarcoma.Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patientsComparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.Osteosarcoma Overview.Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective studyPreliminary clinical research on epiphyseal distraction in osteosarcoma in children.miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.CORR Insights(®): survival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the kneeSurvival, recurrence, and function after epiphyseal preservation and allograft reconstruction in osteosarcoma of the knee.Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysisPerioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review.Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments.Improvement in High-Grade Osteosarcoma Survival: Results from 202 Patients Treated at a Single Institution in TaiwanProton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bedEffect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma.The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas.Osteosarcoma follow-up: chest X-ray or computed tomography?Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.The indications and efficacy of conventional chemotherapy in primary and recurrent sarcoma.Developing a prognostic model for patients with localized osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate: A single-center experience of 237 patients.An update on chemotherapy for osteosarcoma.Metastatic osteosarcoma: a challenging multidisciplinary treatment.Telangiectatic osteosarcoma: a review of 87 cases.Is There Benefit to Free Over Pedicled Vascularized Grafts in Augmenting Tibial Intercalary Allograft Constructs?Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system.Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).Risk-Based Therapy for Localized Osteosarcoma.Marrow signal mimicking tumor on MRI T1-weighted imaging after neoadjuvant chemotherapy in extremity osteosarcomas.GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagy.Shikonin promotes adriamycin‑induced apoptosis by upregulating caspase‑3 and caspase‑8 in osteosarcoma.Clinical efficacy of preoperative chemotherapy with or without ifosfamide in patients with osteosarcoma of the extremity: meta-analysis of randomized controlled trials.Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients.Advances in limb salvage treatment of osteosarcoma.Malignant bone tumors (other than Ewing's): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS).
P2860
Q26775998-67AB9B4F-2CBE-4C01-A118-7BAC0BAE33B2Q28077590-F77685D4-D5A8-43F7-8551-5F79DF31AA02Q28084433-9A10DF92-D1D3-48FB-A181-E7CE37EBF033Q33413207-EB9D221D-9151-4228-A37B-9968DFC8B28FQ33418510-C8AAF744-7B2A-4799-80C3-CFA1F7BBC6C1Q33434899-596CF4BF-9242-4DFD-9DDC-B61CA54D996FQ33692066-09F498B4-F590-4986-B849-51A1F2D0AB43Q33725511-81E63E75-A90C-40B3-A946-EE8D183343ADQ33758207-60789AF3-5E1B-4BBF-8C44-A73DA249C35FQ34042572-B35B36B2-2E6E-4B04-8921-50EDA610619CQ34619410-458C4889-FE18-4161-93EC-E0B265874A83Q35103838-6E524E90-43A3-4141-9782-FC48A5331DC7Q35267836-12F61693-6918-4BF3-B903-244B6829EFE8Q35267874-7EE7A584-A51B-4429-A2D7-AF61D2E27FE8Q35826810-EA0FE5EA-518C-423D-83BD-4820C60FB1B0Q35848126-4E0991D8-1556-473A-82AB-0B82E0BB4C62Q35945493-2C91373B-0828-4C12-97F5-37028F2015C0Q36822586-EC8EA3FA-2E3E-4693-8199-480EED6A16B3Q37273398-2FE4395C-07D5-4436-91DA-1BCAAD04F8BDQ37483652-078A9028-ECFE-40FE-9C4F-F09028507292Q37560522-3AEA6747-52CF-4E5A-9B99-717DFE0E4B7BQ37640670-FA31FE22-CDAB-41B7-A6B0-48D09E3EDBDAQ37641721-DC67072A-F334-4354-A617-290D776F605BQ38315670-421BA491-56C9-45E1-A359-0CF2B1A42338Q38588532-10DA3F1C-5983-4921-9BFF-3531AA926449Q38619114-23075FCB-A1D0-4AA5-90F4-72F05C25FF67Q38783252-FA9F9091-6AE8-442E-81CB-12176DE2A669Q38911783-320BBD85-1EB9-4B51-88E1-494F9154C1A2Q39084808-73CB2B0C-7EA8-44A7-822C-4B58D76360F9Q39146736-40731833-DCA8-465D-88D0-4604B39AFB9DQ39650774-CF5DA813-9792-45EC-A49D-739DCF86EE26Q41002762-1BDE4F67-0F6D-407F-87E3-CB1225453BC1Q41185936-B2D2233B-32AC-40B9-A0B3-EB5E7AB04F37Q42279632-678E2745-E2A5-40AB-A6A3-1AC2559613C2Q42330104-84A33A0A-CBC4-4205-9154-592B4632F96FQ42347161-DA4334B7-E12A-407C-972C-7878A907CEACQ43654763-AB5EB799-5DE6-4DC7-8E7C-383A6A040748Q46032969-18BEF418-9E2E-4CD8-A3AF-58862356A2F4Q47117024-7624F672-9166-465F-8123-BD992405B2DAQ47133901-24825DA4-8FD6-40D5-821A-ED7E1845109B
P2860
Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@ast
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@en
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@nl
type
label
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@ast
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@en
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@nl
prefLabel
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@ast
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@en
Neoadjuvant chemotherapy with ...... sarcoma group trial ISG/OS-1.
@nl
P2093
P50
P356
P1476
Neoadjuvant chemotherapy with ...... n sarcoma group trial ISG/OS-1
@en
P2093
Alessandra Linari
Alessandro Comandone
Angela Tamburini
Gaetano Bacci
Graziella Cefalo
Marco Alberghini
Rodolfo Capanna
Stefano Ferrari
P304
P356
10.1200/JCO.2011.38.4420
P407
P50
P577
2012-05-07T00:00:00Z